Interleukin 2 trial will try to spark flagging immunity of AIDS patients.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D007376:Interleukin-2